Treatment of Relapses in ANCA-Associated Vasculitis
نویسندگان
چکیده
منابع مشابه
Treatment of ANCA – Associated Vasculitis
ANCA – associated vasculitis (AAV) encompass Wegener granulomatosus (WG), Churg Strauss syndrome (CSS) and Microscopic Polyangiitis (MPA). Granuloma formation characterizes both WG and CSS, while necrotising inflammation of middle to small arteries, pauci-immune glomerulonephritis and production of ANCA typify all three of them. Common clinical and laboratory features point towards common patho...
متن کاملTreatment of ANCA-Associated Vasculitis in Adults
Vasculitis is the general term used to describe diseases associated with inflammation of the blood vessels. This inflammation results in end-organ ischemia and damage with lifethreatening consequences. Treatment is tailored to the type of vasculitis the patient has, prognostic features and disease severity. Two main treatment phases are recognized: induction of remission, and maintenance of rem...
متن کاملProgress in treatment of ANCA-associated vasculitis
Autoantibodies to neutrophil cytoplasmic antigen-associated vasculitis (AAV) is characterised by inflammation of blood vessels. The introduction of immunosuppressive therapy with glucocorticoids and cyclophosphamide transformed AAV from a fatal condition to a largely treatable condition. Over the past 30 years, considerable progress has been made refining immunosuppressive regimens with a focus...
متن کاملUpdates in Treatment of ANCA-associated Vasculitis
Correspondence to: Albert Young Abstract: Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis are devastating diseases with high mortality if left untreated. Combined corticosteroid and cyclophosphamide is an effective treatment but it also carries high risks of adverse events and high relapse rates. Numerous studies endeavor to explore alternative agents. This review aims to exam...
متن کاملVasculitis and Multicenter Trial of Treatment in ANCA Associated Vasculitis
Renal Unit of Internal Medicine, Hachioji Medical Center, Tokyo Medical University, Tokyo; 1Laboratory for Immunopharmacology of Microbial Products, School of Pharmacy, Tokyo University of Pharmacy, Tokyo; 2International Graduate School of Arts and Sciences, Yokohama City University, Yokohama, Japan. Masaharu Yoshida, MD, PhD Mariko Sasaki, MA Iwao Nakabayashi, MD, PhD Masakazu Akashi, MD Tomoh...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Journal of the American Society of Nephrology
سال: 2019
ISSN: 1555-9041,1555-905X
DOI: 10.2215/cjn.06250519